Guillermo AntiñoloJavier AznarAlejandro VallejoEnrique CalderónCarmen SáezLuis M. RealJuan A. PinedaBeatriz Martín-AntonioElisa CorderoMarisa VizueteJavier VitoricaRicardo López MartosJavier AmpueroEloy RivasDavid León JiménezAntonio Pereira-VegaEnrique de ÁlavaFrancisco J. García-HernandezGema L Ramírez-VillarMaría Teresa VargasLuis M BeltránNieves Gómez-CoronadoMaría Jesús Montero CuadradoLuis Fernando López-CortésJuan J BorreroEnrique de AlavaÁngel Rodríguez-VillodresG Martín-GutiérrezElena Aguado-DomínguezCarmen Bernal-BellidoEmilio Franco-MacíasJosé Luis López-Campos BodineauJulio ParrillaJ C MateosMiguel Angel Gómez BravoB Santos RamosF J MoralesJose L Gutierrez-PerezIsrael OlivasF Pareja Ciuró
P108
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular CarcinomaAn Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML)A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerAdjuvant Palbociclib in Elderly Patients With Breast CancerExpanded Access Program for Maraviroc At Multiple CentersPazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell CarcinomaStudy in Infants With Infantile Hemangioma to Compare Propranolol Gel to PlaceboClinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsThe Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsEscalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid TumorsA 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial HypercholesterolemiaNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic LeukemiaTislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction CarcinomaA Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Subjects With Manifestations of Plaque Psoriasis and Impaired Quality of Life.The Efficacy and Security of the Small Stitch Technique in Emergency SurgeryA Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular InvolvementTRimetazidine for acUte on Chronic Liver Failure STudySafety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to TherapyStudy of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With Squamous Non-small Cell Lung Cancer (NSCLC)Seville Cohort of People Living With HIV at Risk for Anal CancerSafety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular LymphomaA Study of FT 2102 in Participants With Advanced Solid Tumors and Gliomas With an IDH1 MutationEfficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell TransfusionsVedolizumab in the Prophylaxis of Intestinal Acute Graft vs Host Disease in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) TransplantationTime-based Register and Analysis of COPD EndpointsThRombosis ExclUsion STudyExtended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid.A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic LeukemiaBAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial InfarctionAdipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's DiseaseThe Efficacy of the Administration of Fibrinogen in Liver TransplantationAtypical Hemolytic-Uremic Syndrome (aHUS) RegistryStudy on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically SStudy of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple MyelomaEffectiveness of Different Exercise Training Programs to the Profile of COPD Patients
P6153
Q21853639-6998908b-4786-effa-0b39-60520f5cacafQ39051041-462CC7A7-C3C6-48BC-B257-059E47E787EDQ39546697-2903EB97-7F37-4414-BE2A-F39AC10D936FQ39546843-1450EE53-7C6F-4237-894E-4576DE160076Q40263990-03231772-930B-40D8-A372-15ABD9E6D312Q40263990-9C416275-152B-4ABC-814F-5951AF08AD0FQ41008804-1D8A0763-D458-41EC-985A-C0AA5E11727DQ41008859-BBB7BC63-1D03-4EA0-B332-EB0F5F0FF9C7Q41661238-A3D69F70-F469-4B55-89B9-21EA8ED3A569Q41661238-CB580CB0-2661-4DBB-84E9-7EF625E462FDQ43130677-4BF935A2-4BD0-4520-83A4-6C56D94985C2Q43297174-EAF49F59-3730-48EF-B08E-2D1DA0C4D654Q43297198-7CFA9A09-EB7B-415B-BDE1-069B9E529359Q46159824-18122E16-6101-4F5B-8FCC-0BEB55708814Q55457329-7F423F4A-0D85-4A03-9BE2-777D7BB92DC3Q55718362-6B09AB51-0B40-400B-BF31-E6D8C0B0DF76Q56945501-0F672F81-DA5A-4E7F-8B3B-86D15BBD15EDQ57152830-DE1B955D-AC5E-4E5B-B091-712286BB77B2Q5833990-78EE5F05-0BFE-4320-9C4D-DD6EE470342BQ58467781-DFC15782-1617-4A00-A136-C975C3132545Q58695211-462C8DD8-15DB-410F-B298-32FF94A06820Q58888783-49EDCA9E-4CAC-41AC-A0B9-3BDD0740C7A2Q59162107-0EDF6338-627E-4656-865C-DBD63EC7F29EQ59823156-9B47BD6D-618F-4A90-B1F6-03B525BFFCC3Q6003983-97683db3-4e8d-42ae-32a4-b55411c76a0eQ60309705-76799FE0-D40D-43BE-9E56-0B69706F70C6Q60329608-1A3DD3CA-51E2-4B0A-9D87-E804C2922198Q60674757-4A8BDFC7-2066-4E3F-A6A1-9110AED1CB92Q61122712-DC078F9E-2A52-4175-9BD6-362EC9809FBDQ61122722-B169DCF1-233B-4CF7-9BC6-B4F811898491Q61161839-13BB0002-2CAE-4516-B628-D79F8278045BQ64008590-3AED7635-EC31-4C1C-A3B2-574F79CA0391Q64684185-B9690870-1ED9-481E-BE64-385FC9F7D403Q64854590-4F7C798C-FA15-4241-9EBC-2564D867E120Q64913505-B8CE5923-DABE-4C47-ACF8-1A915F97E9DFQ68638331-4F1C4ECA-F210-40C7-8094-F80966F8125FQ70175692-B9C0FAE4-C00F-4B66-B991-D02BD1E4F653Q72649394-56F8DF93-10F1-45D5-BFA7-82D4C946857DQ73265794-E47D63B6-A726-4A58-ACAF-86B02D8EB8DFQ73310396-1CE52693-8C47-41DD-94B8-B1C205AF7125
P108
Q61862160-0B4124C9-B219-4C7D-BB4D-F40543CD027AQ61862174-CF1533AA-AA26-4CE2-A6EB-288A15DD792CQ61894354-5251B935-322B-4BB9-AA85-809D81EB7A32Q61906992-86552287-1323-4083-8BB2-ACAD2331760DQ61921417-9D0B0835-9AEC-439F-B447-9E2FDA1040AFQ61955706-B92C5EBA-D4BD-48AC-8DA7-73C051BF7A73Q61955909-6B45958C-CA77-4BD3-B7D1-ECC21CF95D49Q61956389-A7928C66-2FC2-4316-BE71-169D31E56B87Q61974962-CE428B38-A7F8-42D4-947C-F06B6846A504Q61974963-596EBEB2-A99C-4418-8B34-3C6EC4D6A505Q61975351-A1E72FE3-A4E4-4F90-ADBA-91682C783907Q61975471-00DD7045-A1D8-4A2D-86F1-EC0BFA0E88C7Q61975843-3CF02318-194E-4110-A602-CA2EA1015F04Q61980068-CADC43A0-AE4C-46EB-9AB9-ACC9DA3649B1Q62030726-1D0C97FE-6322-48F5-9FD9-F0916B00B8F2Q62030939-1BC7AD8F-E7C8-4A76-BC9D-4E02EB346EA5Q62031825-6CD92B35-313F-4ECA-8A6C-4C120490A4C1Q62031862-9118D6FE-C44A-4693-B2B9-0447CB7D85D9Q62035308-E2AC5A04-89DE-4D01-A6B9-66C05E6614D5Q62035396-B58DADCC-4158-4ED1-B944-AC611DF40F64Q62040091-6020114A-5FA0-4BD0-9EA8-E396A7CD70EEQ62040624-1322BC89-A0CE-48ED-A115-99458F3498AEQ62041484-8C79E4CA-AE09-4EC1-B2B8-6319982D7A23Q62054581-2B2770FF-C7DC-4E98-B006-D2C1FE539802Q62054628-528CFB22-94E9-4AD8-99AF-69087C2AFB6DQ62054807-0D21C8BD-D461-4A23-9961-228D093186C2Q62062643-722A044D-C8FF-42B9-AC0A-E24666B75DE3Q62809514-5053D83B-3AA9-4ED6-AB12-407C99F236EBQ62812708-BF6680C1-AD46-4725-BBA8-2879AD428FFDQ63012949-4FF75678-95DB-4E3B-8CB1-04A81E0C5E25Q63013706-F2C1B212-D8C3-4082-8D69-95245E22DB91Q63315798-1D73E9D7-C47F-4EE6-9A5F-AE672037CC0CQ63317356-A23468D8-01C2-42A5-B1A3-615FD8DF6BD2Q63318835-89058A8F-4881-48CC-B2B0-C1BCF38A5CB3Q63319638-8581AA9D-8E48-4FEA-9939-80B6B93FE5B5Q63319884-0267B644-C408-4E4A-B926-95F8B7949C58Q63320337-26AE9F2A-9D2C-4B20-8697-F88E3D1D04E2Q63320949-F8B860EE-31AC-4E23-9F78-8B28DD929DE9Q63322078-1F6654A4-3CC9-4C47-8129-A69EED573AAEQ63335845-0818BF4D-F665-4C4C-A62A-8A2D83AA9F1F
P6153
description
Krankenhaus in Spanien
@de
hospital a Espanya
@ca
hospital em Espanha
@pt
hospital en España
@es
hospital en España
@gl
hospital in Spain
@en
hospital n'España
@ast
hôpital en Espagne
@fr
ospedale in Spagna
@it
ospitalea Espainian
@eu
name
Hospital Universitari Virgen del Rocío
@ca
Hospital Universitario Virgen del Rocío
@en
Hospital Universitario Virgen del Rocío
@es
Hospital Universitario Virgen del Rocío
@nl
Hospital Universitario Virgen del Rocío
@sv
Hôpitaux universitaires Virgen del Rocío
@fr
университетская больница Вирхен дель Росио
@ru
type
label
Hospital Universitari Virgen del Rocío
@ca
Hospital Universitario Virgen del Rocío
@en
Hospital Universitario Virgen del Rocío
@es
Hospital Universitario Virgen del Rocío
@nl
Hospital Universitario Virgen del Rocío
@sv
Hôpitaux universitaires Virgen del Rocío
@fr
университетская больница Вирхен дель Росио
@ru
altLabel
Hopitaux Universitaires Virgen del Rocio
@fr
Hospital Universitario Virgen del Rocio
@en
Hospital Universitario Virgen del Rocio
@es
Hospital Universitario Vírgen del Rocío
@es
Hospital Virgen del Rocio
@es
Hospital Virgen del Rocío
@es
Hôpital Virgen del Rocio
@fr
Hôpital Virgen del Rocío
@fr
Hôpitaux Universitaires Virgen Del Rocío
@fr
Hôpitaux Universitaires Virgen del Rocío
@fr
prefLabel
Hospital Universitari Virgen del Rocío
@ca
Hospital Universitario Virgen del Rocío
@en
Hospital Universitario Virgen del Rocío
@es
Hospital Universitario Virgen del Rocío
@nl
Hospital Universitario Virgen del Rocío
@sv
Hôpitaux universitaires Virgen del Rocío
@fr
университетская больница Вирхен дель Росио
@ru
P527
P214
P646
P950
P131
P1329
+34-955-01-34-66
P17
P213
0000 0000 9542 1158
P214
P2427
grid.411109.c
P2900
+34-955-01-34-65